AUTHOR OF THIS BLOG

DR ANTHONY MELVIN CRASTO, WORLDDRUGTRACKER

Lupin to co-market Novartis’ asthma drug in India

 Uncategorized  Comments Off on Lupin to co-market Novartis’ asthma drug in India
May 112016
 

Lupin to co-market Novartis’ asthma drug in India

Business Standard

BS B2B Bureau  |  Mumbai April 12, 2016 Last Updated at 10:27 IST

Novartis Healthcare will continue to market Sequadra (indacaterol/glycopyrronium inhaler), while Lupin will promote the inhaler under the brand name Loftair in India

read original article at

http://www.business-standard.com/content/b2b-pharma/lupin-to-co-market-novartis-asthma-drug-in-india-116041200249_1.html

 

/////inhaler, Novartis Healthcare,  Sequadra, indacaterol, glycopyrronium inhaler,  Lupin,  inhaler,  brand name,  Loftair, India

Share
Follow

Get every new post on this blog delivered to your Inbox.

Join other followers: